Clinical Practice Guideline for the Management of Chronic Kidney Disease-Mineral and Bone Disorder

被引：356

作者：

Fukagawa, Masafumi ^{[1
]}

Yokoyama, Keitaro ^{[1
]}

Koiwa, Fumihiko ^{[1
]}

Taniguchi, Masatomo ^{[1
]}

Shoji, Tetsuo ^{[1
]}

Kazama, Junichiro James ^{[1
]}

Komaba, Hirotaka ^{[1
]}

Ando, Ryoichi ^{[1
]}

Kakuta, Takatoshi ^{[1
]}

Fujii, Hideki ^{[1
]}

Nakayama, Msasaaki ^{[1
]}

Shibagaki, Yugo ^{[1
]}

Fukumoto, Seiji ^{[2
]}

Fujii, Naohiko ^{[1
]}

Hattori, Motoshi ^{[1
]}

Ashida, Akira ^{[1
]}

Iseki, Kunitoshi ^{[1
]}

Shigematsu, Takashi ^{[1
]}

Tsukamoto, Yusuke ^{[1
]}

Tsubakihara, Yoshiharu ^{[1
]}

Tomo, Tadashi ^{[1
]}

Hirakata, Hideki ^{[1
]}

Akizawa, Tadao ^{[1
]}

机构：

[1] Japanese Soc Dialysis Therapy, Tokyo, Japan

[2] Japanese Soc Nephrol, Tokyo, Japan

来源：

THERAPEUTIC APHERESIS AND DIALYSIS | 2013年 / 17卷 / 03期

关键词：

Chronic kidney disease-Mineral and Bone Disorders; Clinical practice guideline; Parathyroid hormone; Serum Calcium; Serum phosphorus; Vascular calcification; CHRONIC-RENAL-FAILURE; CORONARY-ARTERY CALCIFICATION; GROWTH-FACTOR; 23; ACTIVE VITAMIN-D; AMBULATORY PERITONEAL-DIALYSIS; PARATHYROID-HORMONE LEVELS; ETHANOL INJECTION THERAPY; BETA(2)-MICROGLOBULIN ADSORPTION COLUMN; CHRONIC-HEMODIALYSIS PATIENTS; SERUM ALKALINE-PHOSPHATASE;

D O I：

10.1111/1744-9987.12058

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：247 / 288

页数：42

共 50 条

[1] Calcimimetics in the chronic kidney disease-mineral and bone disorder
Bover, Jordi
Aguilar, Armando
Baas, Juan P.
Reyes, Joselyne
Lloret, Maria-J.
Farre, Neus
Olaya, Mayte
Canal, Cristina
Marco, Helena
Andres, Enric
Trinidad, Pedro
Ballarin, Jose
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2009, 32 (02) : 108 - 121
[2] A rat model of chronic kidney disease-mineral bone disorder
Moe, Sharon M.
Chen, Neal X.
Seifert, Mark F.
Sinders, Rachel M.
Duan, Dana
Chen, Xianming
Liang, Yun
Radcliff, J. Scott
White, Kenneth E.
Gattone, Vincent H., II
KIDNEY INTERNATIONAL, 2009, 75 (02) : 176 - 184
[3] Chronic Kidney Disease-Mineral and Bone Disorder in Asia
Fukagawa, Masafumi
Komaba, Hirotaka
KIDNEY DISEASES, 2017, 3 (01) : 1 - 7
[4] Is there a role for newer biomarkers in chronic kidney disease-mineral and bone disorder management?
Tan, Sven-Jean
Cai, Michael M. X.
NEPHROLOGY, 2017, 22 : 14 - 18
[5] Treatment of Pediatric Chronic Kidney Disease-Mineral and Bone Disorder
Hanudel, Mark R.
Salusky, Isidro B.
CURRENT OSTEOPOROSIS REPORTS, 2017, 15 (03) : 198 - 206
[6] Imaging of Chronic Kidney Disease-Mineral and Bone Disorder
Whitehouse, Richard William
Ahmad, Gulraiz
Kirwadi, Anand
Howard, James Matthew
RADIOLOGIC CLINICS OF NORTH AMERICA, 2022, 60 (04) : 547 - 559
[7] Pathophysiology of chronic kidney disease-mineral and bone disorder
Mac Way, Fabrice
Lessard, Myriam
Lafage-Proust, Marie-Helene
JOINT BONE SPINE, 2012, 79 (06) : 544 - 549
[8] The Kidney-Vascular-Bone Axis in the Chronic Kidney Disease-Mineral Bone Disorder
Seifert, Michael E.
Hruska, Keith A.
TRANSPLANTATION, 2016, 100 (03) : 497 - 505
[9] Guideline-Practice Gap in the Management of Predialysis Chronic Kidney Disease Mineral Bone Disorder in Japan
Hamano, Takayuki
Fujii, Naohiko
Matsui, Isao
Nakano, Chikako
Inoue, Kazunori
Tomida, Kodo
Mikami, Satoshi
Okada, Noriyuki
Tsubakihara, Yoshiharu
Rakugi, Hiromi
Isaka, Yoshitaka
THERAPEUTIC APHERESIS AND DIALYSIS, 2011, 15 : 2 - 8
[10] KDIGO 2017 CLINICAL PRACTICE GUIDELINE UPDATE FOR THE DIAGNOSIS, EVALUATION, PREVENTION, AND TREATMENT OF CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER (CKD-MBD)
KIDNEY INTERNATIONAL SUPPLEMENTS, 2017, 7 (01) : 1 - +

← 1 2 3 4 5 →